FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomy
Carcinogenesis Sep 30, 2017
Tsourlakis MC, et al. - FOXA1 had been identified as a transcription factor involved in androgen signaling with relevance for lineage specific gene expression of the prostate. Authors here aimed at investigating FOXA1 expression by immunohistochemistry on a tissue microarray containing 11,152 prostate cancer specimens. As per findings, high expression of FOXA1 was an independent prognostic parameter in ERG negative prostate cancer. Thus suggesting that FOXA1 measurement could provide clinically useful information in prostate cancer.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries